Which hedge funds own BHVN? BIOHAVEN LTD, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in BHVN (BIOHAVEN LTD) in their Q2 2026 13F filings, worth $406.0m in total. The largest holder by portfolio weight is Suvretta Capital Management at 3.2% of its book. 1 manager opened a new position this quarter: Rubric Capital Management. 1 exited: Brevan Howard Capital Management.
10tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold BHVN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 3.2% | $153.1m | 10,286,937 | 0% | held |
| Woodline Partners | Q2 2026 | 0.4% | $114.0m | 7,660,280 | 2450% | added |
| Rubric Capital Management | Q2 2026 | 0.2% | $25.6m | 1,721,493 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $62.4m | 4,190,195 | 47% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $24.1m | 1,619,676 | -6% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $7.3m | 491,918 | 32% | added |
| Marshall Wace | Q2 2026 | 0.0% | $9.7m | 651,349 | 85% | added |
| Tudor Investment | Q2 2026 | 0.0% | $1.4m | 92,773 | 11% | added |
| Millennium Management | Q2 2026 | 0.0% | $6.2m | 417,534 | -71% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.2m | 150,752 | -6% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $585.0k |
How has hedge fund ownership of BHVN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $406.0m |
| Q1 2026 | 10 | $149.3m |
| Q4 2025 | 4 | $124.5m |
| Q3 2025 | 7 | $108.0m |
| Q2 2025 | 5 | $110.8m |
| Q1 2025 | 7 | $309.1m |
| Q4 2024 | 8 | $485.8m |
| Q3 2024 | 7 | $629.2m |
| Q2 2024 | 7 | $369.7m |
| Q1 2024 | 7 | $404.1m |
| Q4 2023 | 8 | $478.1m |
| Q3 2023 | 7 | $249.2m |
| Q2 2023 | 8 | $230.0m |
| Q1 2023 | 6 | $151.0m |
| Q4 2022 | 7 | $134.4m |
| Q3 2022 | 3 | $4.3m |
Counts every tracked manager that disclosed BHVN in that quarter's filing, including managers that have since stopped filing.